首页> 外文期刊>International Journal of Nanomedicine >Enhanced photo/chemo combination efficiency against bladder tumor by encapsulation of DOX and ZnPC into in situ-formed thermosensitive polymer hydrogel
【24h】

Enhanced photo/chemo combination efficiency against bladder tumor by encapsulation of DOX and ZnPC into in situ-formed thermosensitive polymer hydrogel

机译:通过将DOX和ZnPC封装到原位形成的热敏聚合物水凝胶中提高了对膀胱肿瘤的光/化学结合效率

获取原文
           

摘要

Background: Chemotherapy after transurethral resection is commonly recommended for bladder cancer. However, studies have shown that chemotherapy solely can hardly decrease progression rates of bladder cancer. The combination of chemotherapeutic agents with photodynamic therapy (PDT), a new promising localized therapy, may become a workable strategy for combating bladder cancer. This study reports the combination of doxorubicin (DOX)-based chemotherapy and zinc phthalocyanine (ZnPC)-based PDT using in situ-formed thermal-responsive copolymer hydrogel. Materials and methods: The copolymer was synthesized by polymerization of 3-caprolactone, 1,4,8-trioxa[4.6]spiro-9-undecanone and poly(ethylene glycol) and was abbreviated as PCL-PTSUO-PEG. The thermal-responsive nanoparticles (TNPs) were prepared by the nanoprecipitation technology. The thermal-responsive hydrogel was formed after 37°C heating of TNP solution. The size, morphology and dynamic viscosity of hydrogel were detected. The in vitro drug release profile of TNP/DOX/ZnPC was performed. Cell uptake, cell inhibition and ROS generation of TNP/DOX/ZnPC were studied in 5637 cells. The in?vivo antitumor activity of TNP/DOX/ZnPC was evaluated in nude mice bearing 5637 cells xenograft. Results: TNP/DOX and TNP/ZnPC had an average diameter of 102 and 108?nm, respectively. After being heated at 37°C for 5?minutes, TNP/DOX and TNP/ZnPC solution turned uniform light red and dark green hydrogel. ZnPC encapsulation designed by TNP could significantly improve its aqueous solubility to 1.9?mg/mL. Cell inhibition showed that the best cell inhibition was found, with cell viability of 18.5%, when the weight ratio of DOX and ZnPC encapsulated in the TNP reached about 1:5. TNP/DOX/ZnPC generated relative high level of ROS with 4.8-fold of free ZnPC and 1.6-fold of TNP/ZnPC. TNP/DOX/ZnPC showed only 8-fold of relative tumor growth without obvious toxicity to the mice. Conclusion: Thermosensitive thermal-responsive hydrogel reported in this contribution are promising in situ-formed matrix for DOX- and ZnPC-based photo/chemo combination treatment for bladder cancer therapy.
机译:背景:膀胱癌通常建议采用经尿道切除后的化学疗法。但是,研究表明,仅靠化学疗法几乎无法降低膀胱癌的进展率。化学治疗剂与光动力疗法(PDT)的结合是一种新的有前途的局部疗法,可能成为对抗膀胱癌的可行策略。这项研究报告了使用原位形成的热响应共聚物水凝胶将基于阿霉素(DOX)的化疗和基于酞菁锌(ZnPC)的PDT结合使用。材料与方法:该共聚物是由3-己内酯,1,4,8-三恶英[4.6] spiro-9-十一烷酮和聚乙二醇聚合而成的,缩写为PCL-PTSUO-PEG。通过纳米沉淀技术制备了热响应性纳米颗粒(TNP)。 TNP溶液在37°C加热后形成热响应水凝胶。检测了水凝胶的大小,形态和动态粘度。进行了TNP / DOX / ZnPC的体外药物释放曲线。在5637个细胞中研究了TNP / DOX / ZnPC的细胞摄取,细胞抑制和ROS生成。在携带5637个异种移植瘤的裸鼠中评估了TNP / DOX / ZnPC的体内抗肿瘤活性。结果:TNP / DOX和TNP / ZnPC的平均直径分别为102和108?nm。在37°C加热5分钟后,TNP / DOX和TNP / ZnPC溶液变成均匀的浅红色和深绿色水凝胶。用TNP设计的ZnPC封装可以显着提高其水溶性至1.9?mg / mL。细胞抑制作用表明,当包裹在TNP中的DOX和ZnPC的重量比达到约1:5时,发现最佳的细胞抑制作用是细胞活力为18.5%。 TNP / DOX / ZnPC产生相对较高水平的ROS,其中游离ZnPC为4.8倍,TNP / ZnPC为1.6倍。 TNP / DOX / ZnPC仅显示相对肿瘤生长的8倍,对小鼠无明显毒性。结论:在此贡献中报告的热敏性热响应水凝胶有望成为用于DOX和ZnPC的光/化学联合治疗膀胱癌的原位形成基质。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号